Skip to main content
OpenTrials
Completed

NCT Number: NCT03281967

Clinical Survey of Minimally Invasive Ponto Surgical Technique (MIPS)

The objective of the study is to compare the outcomes after a surgical procedure with minimally invasive Ponto surgery (MIPS, test group) and tissue preservation surgery (control) for placing Oticon Medical Ponto implants and abutments.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bone Conduction Deafness Ear Diseases Hearing Disorders Hearing Loss Hearing Loss, Mixed Conductive-Sensorineural Hearing Loss, Unilateral Middle Ear Deafness Mixed Hearing Loss Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms Unilateral Deafness

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Medical Center St Radboud

Nijmegen, 6500, Netherlands

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years or older.
  • Patient indicated for an ear level bone anchored sound processor.
  • Healthy bone quality to allow for 4mm implant insertion.

Exclusion criteria

  • Intraoperative switch to an alternative surgical technique
  • Patients undergoing re-implantation (on the side being included in the study)
  • Previous participation in the C47 study.
  • Inability to participate in follow-up.
  • Psychiatric disease in the medical history.
  • Mental disability.
  • Presumed doubt, for any reason, that the patient will be able to show up on all follow-ups.
  • Diseases or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.
  • Patients with natural skin height of >12mm (as there will be additional skin reduction needed)

Treatment and study plan

Minimally Invasive Ponto Surgery

Device

Minimally Invasive Ponto surgery is used for hearing rehabilitation using Ponto Wide Implant in patients indicated and counselled for Bone Anchored Hearing System.

Primary outcomes

  1. Numbness (sensibility) around surgery area

    Time frame: 6 months post surgery

    The primary objective of the study is to investigate the difference in numbness around implant after MIPS procedure (test, this investigation) and a surgery with soft tissue preservation (control, from a previous study, C47) for implanting Oticon Medical implants and abutments.

    Two different sensibilities will be tested by means of a broken wooden cotton swab/bud (q-tip): gnostic (with cotton side) and vital (with broken, sharp wooden side) sensibility. The measurement locations will be standardized at specific positions from surgery location, and the same location (with respect to the surgery site) will be used for sensibility measurement for each patient visit. Both the area (diameter in cm) and the degree (scale form 0 (no complaints) to 10 (maximum complaints)) will be monitored. Additionally, patients' subjective sensibility judgment around surgery area on a scale of 0-10 will be recorded.

Secondary outcomes

  1. Time needed for surgery

    Time frame: At surgery

    Compare the surgical time between test (this investigation) and control group (previous investigation, C47).

  2. Unplanned visit

    Time frame: 36 months

    Investigate and compare the number of unplanned visits, unplanned surgical procedures and other treatments for the test (this investigation) and control group (previous investigation, C47).

  3. Adverse Events

    Time frame: 36 months

    Investigate and compare the rate of adverse skin reactions using the Holgers Scale and the IPS scale.

  4. Pain perception by patient

    Time frame: 36 months

    Investigate and compare patient perceived pain.

    For pain measurement, the patient is asked if pain around the implant is present. If it's present, duration is assessed (more or less than 6 weeks present). In addition, increase of pain is assessed during manipulation of the abutment (tightening of or tapping on the abutment). The patient is asked to score the perceived pain on a scale of 0-10; with 0 being no pain at all and 10 being the highest pain the patient had ever experienced.

  5. Implant survivability

    Time frame: 36 months

    Investigate and compare implant survivability.

    Implant survivability is monitored by following upon patients and recording implant losses if and when they occur. The investigators do not expect multiple patients to have an implant loss. However, this may happen due to different reasons. The investigators would track the circumstances under which the implant loss occurred and the time between implant installation and loss.

  6. Implant stability as measures by Implant stability quotient.

    Time frame: 36 months

    Investigate implant stability.

  7. Surgical wound healing time

    Time frame: 36 months

    Investigate and compare healing time after surgery.

    Follow-up visits after surgery will assess the healing of wound. This will be a yes/no assessment to be answered by the attending physician. The investigators will also evaluate skin reactions using the Holgers Scoring Scheme and record any medications that were given to aid in skin healing.

  8. Quality of Life Assessment

    Time frame: 36 months

    Investigate and compare subjective benefit as measured by APHAB, GBI and GHSI questionnaires.

  9. Aesthetic Assessment

    Time frame: 36 months

    Investigate and compare scar assessment by surgeon and patient (POSAS).

Sponsors and collaborators

Lead sponsor

Oticon Medical

Industry

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2020
First posted
Sep 13, 2017
Registry last updated
Mar 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.